Live Breaking News & Updates on பிரஞ்சு சந்தை அதிகாரம்
Stay updated with breaking news from பிரஞ்சு சந்தை அதிகாரம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Veolia Takes Note of the Statements by Ardian's Management That the Fund Is Not Working on a Counter-project for Suez finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
(2) Regulatory News: Pherecydes Pharma (Paris:ALPHE) (FR0011651694 ALPHE), a biotechnology company specializing in precision phage therapy for the treatment of resistant and/or complicated bacterial infections, today announced that the United States Patent and Trademark Office (USPTO) has granted two patents for its anti-Pseudomonas Aeruginosa and Guy-Charles Fanneau de La Horie, CEO of Pherecydes Pharma, says: We are very pleased that the USPTO has granted us these two new patents for our anti-Pseudomonas aeruginosa and anti-E. Coli phages. These two new patents in the world s leading healthcare market greatly expand the geographical areas in which our phages are now protected. This is a further evidence of the relevance of the intellectual property strategy we have implemented. We will continue to protect our champion phages with this now proven strategy. ....
Resounding Success of Pherecydes Pharma s IPO on the Euronext Growth Market in Paris Offer oversubscribed 4 times, with global demand totaling €28.1 million Capital increase of approximately €8 million, after full exercise of the Extension Clause Trading in the Company s shares begins on February 5, 2021 (FR0011651694 ALPHE) Regulatory News: Pherecydes Pharma (Paris:ALPHE) (FR0011651694 ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today announces the resounding success of its initial public offering on the Euronext Growth market in Paris. Guy-Charles Fanneau de La Horie, Chairman of the Executive Board of Pherecydes Pharma, says: I am particularly sensitive to the high level of interest the financial community has shown in our IPO project, both institutional and individual investors. I would like to thank all our shareholders, longstanding and new, who h ....
GROUPE SEB: Biannual Report on SEB S.A. S Liquidity Agreement Entrusted to NATIXIS ODDO BHF - 31st December 2020 GROUPE SEB (Paris:SK): An addendum to the liquidity agreement has been executed on 20 December 2019 with NATIXIS ODDO BHF in accordance with the Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse, the Commission Delegated Regulation (EU) 2016/908 of 26 February 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and the AMF (French Market Authority) decision N° 2018- 01 of 2 July 2018 setting up the liquidity agreements for capital securities as normal market practice. Under the liquidity agreement entrusted by SEB SA (Paris: SK) to NATIXIS ODDO BHF, the following assets appeared on the dedicated liquidity account at ....